@FirebrickPharma thanks for the update , can I ask why this >>
"the primary long term value creation for our company will come from the results of our Phase 3 common cold study"
will give the primary long term value creation ?
I'm new to this area of the market and I would of though that TGA approval would be a catalyst first and foremost?
thanks for your interaction.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
6.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.92M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 6.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.9¢ | 1716 | 1 |
View Market Depth
| Last trade - 09.59am 01/07/2025 (20 minute delay) ? |
| FRE (ASX) Chart |
Day chart unavailable